Perjeta/Herceptin (pertuzumab/trastuzumab)

pCPA File Number: 20767
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Breast Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0018-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: